Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LIXT > SEC Filings for LIXT > Form 8-K on 18-Apr-2014All Recent SEC Filings

Show all filings for LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Form 8-K for LIXTE BIOTECHNOLOGY HOLDINGS, INC.


18-Apr-2014

Unregistered Sale of Equity Securities, Change in Directors or


Item 3.02 Unregistered Sales of Equity Securities

Effective April 15, 2014, Lixte Biotechnology Holdings, Inc. (the "Company") received notices from certain of its warrant holders of the exercise of warrants (the "Warrants") to purchase an aggregate of 3,900,000 shares of the Company's common stock (the "Shares") at exercise prices of $0.25-$0.375. In connection with such exercises, the Company received or will receive an aggregate amount of $1,412,500. No commissions were paid to any party.

The Shares, when issued, will not be registered under the Securities Act of 1933, as amended (the "Act") in reliance upon the exemption from registration contained in Section 4(a)(2) of the Act and Regulation D promulgated thereunder. The Shares may not be reoffered or sold in the United States by the holders in the absence of an effective registration statement or exemption from the registration requirements of the Act.

The Company intends to use the proceeds from the exercise of the Warrants to pay for its ongoing clinical trial, maintenance of its patient portfolio and for general corporate purposes.



Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective April 16, 2014, Dr. Mel Sorenson resigned from the Company's Board of Directors.

  Add LIXT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LIXT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.